Bernengo MG - Search Results

1

Multiple primary melanomas: analysis of 49 cases.

Savoia P, Quaglino P, Verrone A, Bernengo MG. Savoia P, et al. Among authors: bernengo mg. Melanoma Res. 1998 Aug;8(4):361-6. doi: 10.1097/00008390-199808000-00010. Melanoma Res. 1998. PMID: 9764812 Review.

2

Prognostic differences across sexes in melanoma patients: what has changed from the past?

Sanlorenzo M, Ribero S, Osella-Abate S, Zugna D, Marenco F, Macripò G, Fierro MT, Bernengo MG, Quaglino P. Sanlorenzo M, et al. Among authors: bernengo mg. Melanoma Res. 2014 Dec;24(6):568-76. doi: 10.1097/CMR.0000000000000093. Melanoma Res. 2014. PMID: 24892954 Free article.

3

Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.

Quaglino P, Osella-Abate S, Cappello N, Ortoncelli M, Nardò T, Fierro MT, Cavallo F, Savoia P, Bernengo MG. Quaglino P, et al. Among authors: bernengo mg. Melanoma Res. 2007 Apr;17(2):75-82. doi: 10.1097/CMR.0b013e328054c667. Melanoma Res. 2007. PMID: 17496782

4

Skin metastases of malignant melanoma: a clinical and prognostic survey.

Savoia P, Fava P, Nardò T, Osella-Abate S, Quaglino P, Bernengo MG. Savoia P, et al. Among authors: bernengo mg. Melanoma Res. 2009 Oct;19(5):321-6. doi: 10.1097/CMR.0b013e32832ac775. Melanoma Res. 2009. PMID: 19641475

5

Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre.

Savoia P, Fava P, Osella-Abate S, Nardò T, Comessatti A, Quaglino P, Bernengo MG. Savoia P, et al. Among authors: bernengo mg. Melanoma Res. 2010 Jun;20(3):227-32. Melanoma Res. 2010. PMID: 20449885 Free article.

6

Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data.

Quaglino P, Savoia P, Fierro MT, Osella-Abate S, Bernengo MG. Quaglino P, et al. Among authors: bernengo mg. Melanoma Res. 2004 Apr;14(2):S17-9. doi: 10.1097/00008390-200404000-00018. Melanoma Res. 2004. PMID: 15057052

7

Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot study.

Bernengo MG, Doveil GC, Bertero M, Quaglino P, Fierro MT, Savoia P, Appino A, Colonna S. Bernengo MG, et al. Melanoma Res. 1996 Jun;6(3):257-65. doi: 10.1097/00008390-199606000-00009. Melanoma Res. 1996. PMID: 8819129 Clinical Trial.

8

CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease.

Savoia P, Fierro MT, Novelli M, Quaglino P, Verrone A, Geuna M, Bernengo MG. Savoia P, et al. Among authors: bernengo mg. Br J Dermatol. 1997 Dec;137(6):966-71. Br J Dermatol. 1997. PMID: 9470917

9

Role of RT-PCR tyrosinase detection in the monitoring of patients with advanced metastatic melanoma.

Osella Abate S, Savoia P, Cambieri I, Salomone B, Quaglino P, Bernengo MG. Osella Abate S, et al. Among authors: bernengo mg. Melanoma Res. 2000 Dec;10(6):545-55. doi: 10.1097/00008390-200012000-00006. Melanoma Res. 2000. PMID: 11198476

10

VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course.

Osella-Abate S, Quaglino P, Savoia P, Leporati C, Comessatti A, Bernengo MG. Osella-Abate S, et al. Among authors: bernengo mg. Melanoma Res. 2002 Aug;12(4):325-34. doi: 10.1097/00008390-200208000-00004. Melanoma Res. 2002. PMID: 12170181

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters